Sol-Gel Technologies (SLGL) Cash & Equivalents (2016 - 2026)

Sol-Gel Technologies (SLGL) reported Cash & Equivalents of $10.1 million for Q1 2026, down 39.99% year-over-year from $16.9 million in Q1 2025, and down 8.13% quarter-over-quarter from $11.0 million in Q4 2025.

Sol-Gel Technologies (SLGL) Cash & Equivalents (2016 - 2026) Analysis & Trends

Sol-Gel Technologies (SLGL) has 11 years of Cash & Equivalents data on file, last reported at $10.1 million in Q1 2026.

  • Cash & Equivalents for Q1 2026 came in at $10.1 million, down 39.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.1 million (down 39.99% YoY), and the FY2025 annual result was $11.0 million, down 43.39% from the prior year.
  • Cash & Equivalents fell to $10.1 million in Q1 2026 per SLGL's latest filing, from $11.0 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $21.3 million in Q1 2022 and troughed at $5.8 million in Q2 2022.
  • A 5-year average of $11.9 million and a median of $11.2 million in 2024 frame the typical range for Cash & Equivalents.
  • The sharpest annual moves came in 2022 and 2023: Cash & Equivalents tumbled 80.39% in 2022, then soared 170.91% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $12.4 million in 2022, then plunged by 39.64% to $7.5 million in 2023, then surged by 159.4% to $19.5 million in 2024, then plunged by 43.39% to $11.0 million in 2025, then decreased by 8.13% to $10.1 million in 2026.
  • Business Quant data shows SLGL's Cash & Equivalents at $10.1 million in Q1 2026, $11.0 million in Q4 2025, and $6.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 1.91 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.15 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.49 Bn
9 Abivax 91.96 Bn 91.96 Bn - 558.94 Mn
10 Sol-Gel Technologies 207.80 Mn 197.67 Mn - 10.14 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.14 Mn
Dec 31, 2025 11.03 Mn
Sep 30, 2025 6.71 Mn
Jun 30, 2025 10.22 Mn
Mar 31, 2025 16.89 Mn
Dec 31, 2024 19.49 Mn
Sep 30, 2024 13.42 Mn
Jun 30, 2024 11.55 Mn
Mar 31, 2024 11.21 Mn
Dec 31, 2023 7.51 Mn
Sep 30, 2023 14.14 Mn
Jun 30, 2023 15.62 Mn
Mar 31, 2023 6.81 Mn
Dec 31, 2022 12.45 Mn
Sep 30, 2022 8.50 Mn
Jun 30, 2022 5.77 Mn
Mar 31, 2022 21.25 Mn
Dec 31, 2021 20.09 Mn
Sep 30, 2021 43.35 Mn
Jun 30, 2021 11.15 Mn